Product Details Product Name: BPC-157 / TB4 Blend 10mg/10mg Form: Lyophilized powder Purity: 99% (HPLC verified) Packaging: Sterile sealed vial Storage: Store in a cool, dry place Intended Use: For laboratory research use only Notice: This material is provided strictly for research purposes only
What to Expect: Timeline and Side Effects Most people notice appetite suppression within 3-5 days of starting tirzepatide, with steady weight loss beginning in week two
Find your water volume on the left, then read across to see what each common dose looks like on your insulin syringe in units
However, this general metabolic support should not be conflated with specific effects on GLP-1 secretion
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 50 H 69 N 15 O 9 Weight: 1024.20 g/mol CAS: 121062-08-6 Structure: Cyclic heptapeptide with lactam bridge PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Soluble in water and acetic acid Selectivity: Non-selective MC1R/3R/4R/5R agonist Storage: Keep refrigerated 3646 F (28 C)
For the estimated 936 million adults worldwide affected by OSA (Benjafield et al., The Lancet Respiratory Medicine , 2019), this represents a meaningful new treatment pathway, though not a replacement for established therapies in all cases